Formulation Development Applications & Studies
-
Rheology Is An Accurate Predictor Of Pharmaceutical Lotion Stability
5/6/2026
Rheological creep testing provides a rapid way to predict pharmaceutical lotion stability by linking steady-state viscosity to particle settling behavior, enabling reliable shelf-life estimates.
-
De-Risking Drug Development: Informatics-Supported Solid Form Selection
5/6/2026
Learn how combining polymorph screening with structural informatics improves solid‑form selection, lowers development risk, and boosts confidence in long‑term stability and manufacturability.
-
Maintain Control Of Pharmaceutical Water Systems
4/10/2026
Early TOC excursions often reveal hidden risks in water systems. Capturing samples at the moment of deviation helps teams confirm root causes faster, reduce uncertainty, and maintain control.
-
Evaluating Carryover When Using A TOC Analyzer
4/10/2026
Accurate TOC results shouldn’t depend on sample order. See how low-level measurements remain reliable even after high-TOC analysis, helping reduce false positives and streamline decisions.
-
Scale-Up Of AAV Production In Fixed-Bed Bioreactors
3/31/2026
Consistent AAV production is critical for manufacturing. See how aligned strategies deliver comparable cell growth, metabolic trends, and rAAV5 titers from development through production.
-
Cost Modeling Analysis Of AAV And LV Manufacturing
3/31/2026
Manufacturing scale plays a critical role in viral vector economics. Compare AAV and LV production scenarios to gain insight into how intermediate-scale strategies can reduce cost and risk.
-
Overcoming Food Effects, Variability, Solubility For A Non-Opioid Analgesic With Lipid-Based Formulations
3/20/2026
Develop optimized lipid-based formulations to overcome solubility, stability, and food-effect challenges, enabling high-dose oral delivery and rapid progression to Phase 1 trials.
-
Overcoming API Constraints And Tight Timelines With On-Demand Manufacturing
3/20/2026
Use innovative lipid-based formulations and on-demand manufacturing to accelerate Phase 1 trials, enable flexible dose escalation, and maximize limited API for poorly soluble compounds.
-
Solving Bioavailability Challenges In bRo5 Drugs
3/20/2026
Leverage mechanistic, material-sparing formulation strategies to enhance bioavailability and accelerate development of challenging bRo5 small molecules, even with limited resources.
-
Leveraging Softgel To Extend Vinorelbine's Lifecycle, Improve Patient Convenience
3/20/2026
Develop innovative oral formulations of traditionally intravenous therapies to enhance patient convenience, ensure consistent systemic exposure, and support long-term brand value and market differentiation.